Abraxis Bioscience LLC v The Comptroller-General of Patents

Core Citations

CONSIDERS

• Neurim Pharmaceuticals (1991) Ltd v The Comptroller-General of Patents
• Sandvik Intellectual Property AB v Kennametal UK Ltd

REFERS TO

• Glaxosmithkline Biologicals Sa v Comptroller-general of Patents, Designs and Trade Marks
• Generics (UK) Ltd v Daiichi Pharmaceutical Company Ltd (Costs)
• Neurim Pharmaceuticals (1991) Ltd v The Comptroller-General of Patents

[See more]

• Yissum Research and Development Company of the Hebrew University of Jerusalem v Comptroller-General of Patents
• Draco AB's SPC Application

APPLIES

• Astrazeneca AB v Comptroller-General of Patents, Designs and Trade Marks

CONSIDERS

• Neurim Pharmaceuticals (1991) Ltd v The Comptroller-General of Patents

REFERRED in

• Merck Serono S.A. v The Comptroller-General of Patents, Designs and Trade Marks
• Newron Pharmaceuticals S.P.A. v The Comptroller General of Patents, Trademarks and Designs

This document cites

• Sandvik Intellectual Property AB v Kennametal UK Ltd
• Neurim Pharmaceuticals (1991) Ltd v The Comptroller-General of Patents
• Astrazeneca AB v Comptroller-General of Patents, Designs and Trade Marks
• Glaxosmithkline Biologicals Sa v Comptroller-general of Patents, Designs and Trade Marks
• Generics (UK) Ltd v Daiichi Pharmaceutical Company Ltd (Costs)



See all quotations

• Yissum Research and Development Company of the Hebrew University of Jerusalem v Comptroller-General of Patents
• Draco AB's SPC Application
• Neurim Pharmaceuticals (1991) Ltd v The Comptroller-General of Patents
• Neurim Pharmaceuticals (1991) Ltd v The Comptroller-General of Patents
• AHP Manufacturing BV v Bureau voor de Industriële Eigendom.
• Arne Forsgren v Österreichisches Patentamt.
• Pharmacia Italia SpA, formerly Pharmacia & Upjohn SpA.
• Davidoff & Cie SA and Zino Davidoff SA v Gofkid Ltd.
• Medeva BV v Comptroller General of Patents, Designs and Trade Marks.
• Neurim Pharmaceuticals (1991) Ltd v Comptroller-General of Patents.
• BASF AG v Bureau voor de Industriële Eigendom (BIE).
• DIR International Film Srl, Nostradamus Enterprises Ltd, Union PN Srl, United International Pictures BV, United International Pictures AB, United International Pictures APS, United International Pictures A/S, United International Pictures EPE, United International Pictures OY y United International Pictures y Cía SRC contra Comisión de las Comunidades Europeas.
• Synthon BV v Merz Pharma GmbH & Co. KGaA.
• Massachusetts Institute of Technology.
• Generics (UK) Ltd v Synaptech Inc.
• Council Regulation (EEC) No 1768/92 of 18 June 1992 concerning the creation of a supplementary protection certificate for medicinal products
• Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use
• Regulation (EC) No 469/2009 of the European Parliament and of the Council of 6 May 2009 concerning the supplementary protection certificate for medicinal products (Codified version) (Text with EEA relevance)
• Regulation (EC) No 1610/96 of the European Parliament and of the Council of 23 July 1996 concerning the creation of a supplementary protection certificate for plant protection products
• Directive 2001/82/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to veterinary medicinal products